Literature DB >> 21310321

Impaired left ventricular stroke volume reserve during clinical dobutamine stress predicts future episodes of pulmonary edema.

Charaslak Charoenpanichkit1, William C Little, Sangeeta Mandapaka, Erica Dall'Armellina, Timothy M Morgan, Craig A Hamilton, W Gregory Hundley.   

Abstract

OBJECTIVES: The purpose of this study was to determine whether dobutamine-induced abnormal stress changes in left ventricular stroke volume (LVSV) and aortic stiffness predict future pulmonary edema.
BACKGROUND: Increased aortic stiffness that decreases LVSV during adrenergic stress may serve as a marker for future pulmonary edema (PE).
METHODS: We measured LVSV, ventriculovascular stiffness (pulse pressure/LVSV(index)), and aortic distensibility at rest and during intravenous dobutamine administration using cardiovascular magnetic resonance. Personnel blinded to dobutamine cardiovascular magnetic resonance followed participants longitudinally over time to identify those admitted to the hospital with PE. Data for 44 participants who had a hospital admission for PE were compared with data for 72 participants of similar age, sex, and resting left ventricular ejection fraction who remained PE free.
RESULTS: Expressed as median and interquartile range, participants with and without PE exhibited a decreased stress/rest LVSV ratio (0.9 [range 0.7 to 1.1] vs. 1.0 [range 0.9 to 1.2], respectively; p = 0.002), an increased ventriculovascular stiffness stress/rest ratio (1.4 [range 1.0 to 1.6] vs. 1.0 [range 0.8 to 1.3], respectively; p ≤ 0.001); and a decreased stress-induced measure of aortic distensibility (0.8 mm Hg(-3) [range 0.3 to 1.3 mm Hg(-3)] vs. 1.6 mm Hg(-3) [range 1.2 to 3.2 mm Hg(-3)], respectively; p = 0.002). After accounting for age, sex, left ventricular ejection fraction, risk factors for PE, and the presence of dobutamine-induced ischemia, LVSV reserve and the stress/rest ventriculovascular stiffness ratio still differed (p < 0.008 for both) in those with and without PE.
CONCLUSIONS: In patients without inducible ischemia during dobutamine stress testing in whom one might otherwise assume a favorable prognosis, the failure to increase LVSV or an increase in ventriculovascular stiffness indicates patients at risk of subsequent PE.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21310321      PMCID: PMC3634344          DOI: 10.1016/j.jacc.2010.10.019

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  33 in total

1.  Is imaging at intermediate doses necessary during dobutamine stress magnetic resonance imaging?

Authors:  C A Hamilton; K M Link; T B Salido; F H Epstein; W G Hundley
Journal:  J Cardiovasc Magn Reson       Date:  2001       Impact factor: 5.364

2.  Cardiovascular physiology during supine cycle ergometry and dobutamine stress.

Authors:  James F Cnota; Wayne A Mays; Sandra K Knecht; Shannon Kopser; Erik C Michelfelder; Timothy K Knilans; Randal P Claytor; Thomas R Kimball
Journal:  Med Sci Sports Exerc       Date:  2003-09       Impact factor: 5.411

3.  Lack of diastolic reserve in patients with heart failure and normal ejection fraction.

Authors:  Sudipta Chattopadhyay; Mohammed F Alamgir; Nikolay P Nikitin; Alan S Rigby; Andrew L Clark; John G F Cleland
Journal:  Circ Heart Fail       Date:  2009-10-22       Impact factor: 8.790

Review 4.  Age-related changes in venticular-arterial coupling: pathophysiologic implications.

Authors:  David A Kass
Journal:  Heart Fail Rev       Date:  2002-01       Impact factor: 4.214

5.  The pathogenesis of acute pulmonary edema associated with hypertension.

Authors:  S K Gandhi; J C Powers; A M Nomeir; K Fowle; D W Kitzman; K M Rankin; W C Little
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

6.  Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance.

Authors:  W G Hundley; D W Kitzman; T M Morgan; C A Hamilton; S N Darty; K P Stewart; D M Herrington; K M Link; W C Little
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

7.  Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization.

Authors:  K Kramer; P Kirkman; D Kitzman; W C Little
Journal:  Am Heart J       Date:  2000-09       Impact factor: 4.749

8.  The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health.

Authors:  Ronald G Victor; Robert W Haley; DuWayne L Willett; Ronald M Peshock; Patrice C Vaeth; David Leonard; Mujeeb Basit; Richard S Cooper; Vincent G Iannacchione; Wendy A Visscher; Jennifer M Staab; Helen H Hobbs
Journal:  Am J Cardiol       Date:  2004-06-15       Impact factor: 2.778

9.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

10.  Pulse pressure/stroke index and left ventricular geometry and function: the LIFE Study.

Authors:  Vittorio Palmieri; Jonathan N Bella; Mary J Roman; Eva Gerdts; Vasilios Papademetriou; Kristian Wachtell; Markku S Nieminen; Björn Dahlöf; Richard B Devereux
Journal:  J Hypertens       Date:  2003-04       Impact factor: 4.844

View more
  7 in total

1.  Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome.

Authors:  Thomas Stiermaier; Francesco Santoro; Tobias Graf; Francesca Guastafierro; Nicola Tarantino; Luisa De Gennaro; Pasquale Caldarola; Matteo Di Biase; Holger Thiele; Natale D Brunetti; Christian Möller; Ingo Eitel
Journal:  Clin Res Cardiol       Date:  2018-04-19       Impact factor: 5.460

2.  Simultaneous measurement of left and right ventricular volumes and ejection fraction during dobutamine stress cardiovascular magnetic resonance.

Authors:  Sangeeta Mandapaka; Craig A Hamilton; Timothy M Morgan; William Gregory Hundley
Journal:  J Comput Assist Tomogr       Date:  2011 Sep-Oct       Impact factor: 1.826

3.  PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design.

Authors:  Margaret M Redfield; Barry A Borlaug; Greg D Lewis; Selma F Mohammed; Marc J Semigran; Martin M Lewinter; Anita Deswal; Adrian F Hernandez; Kerry L Lee; Eugene Braunwald
Journal:  Circ Heart Fail       Date:  2012-09-01       Impact factor: 8.790

4.  Cardiovascular response to exercise training in the systemic right ventricle of adults with transposition of the great arteries.

Authors:  K M Shafer; L Janssen; G Carrick-Ranson; S Rahmani; D Palmer; N Fujimoto; S Livingston; S A Matulevicius; L W Forbess; B Brickner; B D Levine
Journal:  J Physiol       Date:  2015-06-01       Impact factor: 5.182

5.  Increased cardiovascular stiffness and impaired age-related functional status.

Authors:  Mousumi M Andersen; Stephen B Kritchevsky; Timothy M Morgan; Don G Hire; Sujethra Vasu; Tina E Brinkley; Dalane W Kitzman; Craig A Hamilton; Sandra Soots; William G Hundley
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-06-24       Impact factor: 6.053

6.  Mechanism of decreased sensitivity of dobutamine associated left ventricular wall motion analyses for appreciating inducible ischemia in older adults.

Authors:  Sujethra Vasu; William C Little; Timothy M Morgan; Richard B Stacey; William O Ntim; Craig Hamilton; Vinay Thohan; Caroline Chiles; William Gregory Hundley
Journal:  J Cardiovasc Magn Reson       Date:  2015-04-08       Impact factor: 5.364

7.  Abnormal stress-related measures of arterial stiffness in middle-aged and elderly men and women with impaired fasting glucose at risk for a first episode of symptomatic heart failure.

Authors:  Sujethra Vasu; Timothy M Morgan; Dalane W Kitzman; Alain Bertoni; Richard B Stacey; Craig Hamilton; Caroline Chiles; Vinay Thohan; W Gregory Hundley
Journal:  J Am Heart Assoc       Date:  2015-01-14       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.